Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorTimothy Mullett

About this trial

This clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening in Mississippi (MS) and Nevada (NV). The QUILS™ Group is focused on fair and high-quality implementation of lung cancer screening among eligible individuals to reduce lung cancer-related death in underserved communities. Previous research had success with implementing interventions in Kentucky which has lead to significant increases in lung cancer screening rates and a rapid decline in late-stage lung cancer diagnoses within the state. The goal is to offer the opportunity to replicate this work in states which are eager to address suboptimal screening rates, high lung cancer-related death, and significant health equity concerns. The QUILS™ SBI intervention involves translating the success of the initial work in Kentucky to impact lung cancer screening implementation and lung cancer outcomes in MS and NV through close collaboration with state-based partners. The QUILS™ SBI intervention may be an effective way to improve the statewide capacity for implementing and sustaining lung cancer screening in MS and NV.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Member of a state-based lung cancer screening implementation team in Mississippi or Nevada.

Leadership member of the Mississippi state team or Nevada state team

Active member of the Mississippi Lung Cancer Roundtable (MSLCRT) or Nevada Lung Cancer Coalition (NLCC)

Willing to participate in study-related assessments an implementation activities

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • QUILS SBI Intervention

    Behavioral

    Participants implement the QUILS™ SBI intervention over 4 years consisting of the following steps: 1) Hire and establish connections with both groups, work with the MSLCRT and NLCC during year 1; 2) Participate in annual meetings hosted by MSCLRT and NLCC during years 1-4; 3) Attend State Team Assessment Feedback Sessions during years 2-4; 4) Attend Coalition Assessment Feedback Sessions during years 2-4; 5) Prioritize objectives, identify areas to support, implementation of state-based initiative, and receive coaching/support during years 2 and 3; 6) Receive coaching and technical assistance to implement priority areas during years 1-4; 7) Participate in sustainability planning during year 4.

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Health Services Research (SBI Intervention)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Statewide Capacity Assessment Scores for Lung Cancer Screening Implementation and Sustainability Capacity

Statewide capacity will be assessed using the State Team Assessment (STA) and Coalition Assessment (CA) instruments. Higher scores indicate greater capacity to implement an sustain lung cancer screening activities.

Time frame
Up to 3 Years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Timothy Mullett

Lead sponsor

University of Kentucky

Sponsor institution